High drug prices are not justified by industry’s spending on research and development

Author:

Angelis Aris,Polyakov Roman,Wouters Olivier J,Torreele Els,McKee Martin

Publisher

BMJ

Subject

General Engineering

Reference47 articles.

1. Trends in Prescription Drug Launch Prices, 2008-2021

2. Helfand C. Novartis slaps $2m-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve. Fierce Pharma, 24 May 2019. https://www.fiercepharma.com/pharma/novartis-slaps-2m-plus-pricetag-newly-approved-gene-therapy-zolgensma

3. Anderson LA. 10 of the most expensive drugs in the US. Drugs.com 17 Oct 2022. https://www.drugs.com/slideshow/top-10-most-expensive-drugs-1274

4. Helmore E. Gene therapy at $3.5m a dose approved for US adults with hemophilia B. Guardian 2022 Nov 23. https://www.theguardian.com/business/2022/nov/23/hemgenix-hemophilia-b-fda-most-expensive-drug

5. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3